Piotr Zimniak
Concepts (603)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glutathione Transferase | 62 | 2016 | 174 | 5.100 |
Why?
| | Aldehydes | 35 | 2015 | 81 | 3.530 |
Why?
| | Longevity | 7 | 2012 | 85 | 1.470 |
Why?
| | Lipid Peroxidation | 14 | 2016 | 98 | 1.440 |
Why?
| | Isoenzymes | 26 | 2009 | 165 | 1.190 |
Why?
| | Caenorhabditis elegans | 6 | 2011 | 131 | 1.070 |
Why?
| | Carrier Proteins | 22 | 2004 | 315 | 1.000 |
Why?
| | Oxidative Stress | 16 | 2011 | 820 | 0.900 |
Why?
| | Glutathione | 33 | 2009 | 303 | 0.870 |
Why?
| | Bile Acids and Salts | 20 | 2002 | 81 | 0.850 |
Why?
| | Adenosine Triphosphatases | 22 | 2003 | 92 | 0.760 |
Why?
| | Caenorhabditis elegans Proteins | 4 | 2011 | 59 | 0.710 |
Why?
| | Animals | 85 | 2016 | 13528 | 0.690 |
Why?
| | Lithocholic Acid | 12 | 2003 | 20 | 0.670 |
Why?
| | ATP-Binding Cassette Transporters | 14 | 2003 | 35 | 0.620 |
Why?
| | Adenosine Triphosphate | 19 | 2003 | 211 | 0.570 |
Why?
| | GTPase-Activating Proteins | 12 | 2003 | 25 | 0.540 |
Why?
| | Receptors, Muscarinic | 5 | 2003 | 18 | 0.530 |
Why?
| | Xenobiotics | 6 | 2003 | 31 | 0.520 |
Why?
| | Liver | 20 | 2016 | 1150 | 0.520 |
Why?
| | Aging | 4 | 2011 | 715 | 0.510 |
Why?
| | Signal Transduction | 13 | 2011 | 1748 | 0.410 |
Why?
| | Fatty Acids | 3 | 2011 | 154 | 0.390 |
Why?
| | Microsomes, Liver | 12 | 1992 | 183 | 0.380 |
Why?
| | Mice | 32 | 2016 | 5982 | 0.370 |
Why?
| | Geriatrics | 1 | 2012 | 42 | 0.350 |
Why?
| | Cloning, Molecular | 7 | 2009 | 175 | 0.340 |
Why?
| | Doxorubicin | 12 | 2003 | 248 | 0.330 |
Why?
| | Kinetics | 35 | 2004 | 607 | 0.330 |
Why?
| | Obesity | 2 | 2010 | 1205 | 0.330 |
Why?
| | Cell Membrane | 16 | 2009 | 233 | 0.320 |
Why?
| | DNA | 4 | 2009 | 535 | 0.300 |
Why?
| | Substrate Specificity | 22 | 2004 | 197 | 0.300 |
Why?
| | Muscarinic Antagonists | 4 | 2003 | 24 | 0.290 |
Why?
| | Adipose Tissue | 2 | 2008 | 210 | 0.290 |
Why?
| | Molecular Sequence Data | 14 | 2009 | 759 | 0.280 |
Why?
| | Colonic Neoplasms | 4 | 2005 | 162 | 0.280 |
Why?
| | Enzyme Inhibitors | 1 | 2010 | 371 | 0.280 |
Why?
| | Metabolic Detoxication, Phase I | 1 | 2008 | 11 | 0.280 |
Why?
| | Apoptosis | 11 | 2008 | 1139 | 0.270 |
Why?
| | Gene Expression | 4 | 2009 | 618 | 0.270 |
Why?
| | Lipid Metabolism | 1 | 2008 | 189 | 0.260 |
Why?
| | Rats | 31 | 2005 | 3164 | 0.250 |
Why?
| | Calcium | 8 | 1991 | 373 | 0.250 |
Why?
| | Catalysis | 12 | 2009 | 87 | 0.240 |
Why?
| | Growth Inhibitors | 2 | 2005 | 26 | 0.240 |
Why?
| | Chief Cells, Gastric | 2 | 2003 | 2 | 0.230 |
Why?
| | Drosophila melanogaster | 2 | 2003 | 32 | 0.230 |
Why?
| | Alleles | 9 | 2004 | 277 | 0.230 |
Why?
| | Anions | 3 | 1994 | 6 | 0.230 |
Why?
| | Receptor, Insulin | 1 | 2005 | 35 | 0.230 |
Why?
| | Base Sequence | 9 | 2011 | 620 | 0.230 |
Why?
| | Mitogen-Activated Protein Kinases | 8 | 2004 | 152 | 0.230 |
Why?
| | Transfection | 11 | 2009 | 359 | 0.220 |
Why?
| | Glucuronates | 12 | 1992 | 22 | 0.220 |
Why?
| | Erythrocytes | 5 | 2003 | 70 | 0.220 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2015 | 35 | 0.220 |
Why?
| | Leukemia L5178 | 1 | 2005 | 2 | 0.220 |
Why?
| | Citric Acid | 3 | 2010 | 17 | 0.220 |
Why?
| | Thymidine Kinase | 1 | 2005 | 18 | 0.220 |
Why?
| | Blotting, Western | 15 | 2016 | 587 | 0.220 |
Why?
| | Humans | 74 | 2012 | 53246 | 0.220 |
Why?
| | Mutagens | 1 | 2005 | 49 | 0.220 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2009 | 180 | 0.210 |
Why?
| | Biological Transport | 15 | 2003 | 150 | 0.210 |
Why?
| | Carcinogens | 7 | 2002 | 194 | 0.210 |
Why?
| | Amino Acid Sequence | 12 | 2009 | 563 | 0.210 |
Why?
| | Recombinant Proteins | 11 | 2009 | 489 | 0.210 |
Why?
| | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 5 | 2004 | 10 | 0.200 |
Why?
| | RNA Interference | 4 | 2011 | 181 | 0.200 |
Why?
| | Models, Molecular | 9 | 2004 | 352 | 0.200 |
Why?
| | Phospholipids | 8 | 2001 | 59 | 0.200 |
Why?
| | Biological Transport, Active | 15 | 2002 | 29 | 0.200 |
Why?
| | Mutagenesis, Site-Directed | 8 | 2004 | 97 | 0.190 |
Why?
| | Molecular Mimicry | 1 | 2002 | 35 | 0.190 |
Why?
| | Binding Sites | 10 | 2004 | 373 | 0.180 |
Why?
| | Membrane Glycoproteins | 5 | 1994 | 238 | 0.180 |
Why?
| | Taurine | 3 | 2002 | 18 | 0.180 |
Why?
| | Water | 2 | 1999 | 87 | 0.170 |
Why?
| | Chromatography, Affinity | 8 | 2009 | 36 | 0.170 |
Why?
| | K562 Cells | 9 | 2009 | 42 | 0.160 |
Why?
| | Drug Resistance, Neoplasm | 5 | 2003 | 350 | 0.160 |
Why?
| | Cell Line | 8 | 2009 | 1016 | 0.150 |
Why?
| | Aconitate Hydratase | 2 | 2010 | 9 | 0.150 |
Why?
| | Acetyl-CoA Carboxylase | 2 | 2010 | 13 | 0.150 |
Why?
| | Carcinoembryonic Antigen | 1 | 1999 | 13 | 0.150 |
Why?
| | Valine | 3 | 2000 | 58 | 0.150 |
Why?
| | Taurolithocholic Acid | 5 | 2002 | 7 | 0.150 |
Why?
| | Azotobacter | 4 | 1983 | 4 | 0.140 |
Why?
| | Phosphorylation | 7 | 2009 | 533 | 0.140 |
Why?
| | Lipid Peroxides | 4 | 2008 | 10 | 0.140 |
Why?
| | Reactive Oxygen Species | 3 | 2011 | 421 | 0.140 |
Why?
| | Cysteine Proteinase Inhibitors | 4 | 2009 | 21 | 0.140 |
Why?
| | Malonyl Coenzyme A | 2 | 2008 | 7 | 0.140 |
Why?
| | CHO Cells | 6 | 2003 | 124 | 0.140 |
Why?
| | Cricetinae | 6 | 2003 | 190 | 0.140 |
Why?
| | PPAR alpha | 2 | 2016 | 61 | 0.140 |
Why?
| | Escherichia coli | 5 | 2009 | 183 | 0.140 |
Why?
| | Acetylcholine | 5 | 2003 | 56 | 0.130 |
Why?
| | Structure-Activity Relationship | 7 | 2004 | 396 | 0.130 |
Why?
| | Isoleucine | 3 | 2004 | 27 | 0.130 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 579 | 0.120 |
Why?
| | Proteolipids | 7 | 2003 | 10 | 0.120 |
Why?
| | Bile | 4 | 1990 | 23 | 0.120 |
Why?
| | Mice, Knockout | 6 | 2016 | 910 | 0.120 |
Why?
| | Hyperbilirubinemia, Hereditary | 2 | 1993 | 2 | 0.120 |
Why?
| | Lung | 3 | 1996 | 481 | 0.120 |
Why?
| | Hyperbilirubinemia | 2 | 1993 | 8 | 0.110 |
Why?
| | Animals, Genetically Modified | 2 | 2005 | 54 | 0.110 |
Why?
| | Cholestasis | 2 | 1998 | 41 | 0.110 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 90 | 0.110 |
Why?
| | Rats, Inbred Strains | 12 | 1992 | 174 | 0.110 |
Why?
| | Mutation | 4 | 2009 | 1338 | 0.100 |
Why?
| | Antibiotics, Antineoplastic | 3 | 2003 | 84 | 0.100 |
Why?
| | Chrysenes | 3 | 1998 | 3 | 0.100 |
Why?
| | Carcinoma, Hepatocellular | 1 | 1997 | 213 | 0.100 |
Why?
| | Male | 27 | 2014 | 27444 | 0.100 |
Why?
| | Protein Processing, Post-Translational | 3 | 2015 | 149 | 0.100 |
Why?
| | Sodium | 2 | 1993 | 89 | 0.100 |
Why?
| | Genes | 1 | 1994 | 30 | 0.100 |
Why?
| | Organic Anion Transporters, Sodium-Dependent | 1 | 1993 | 3 | 0.100 |
Why?
| | Hydroxysteroid Dehydrogenases | 1 | 1993 | 4 | 0.100 |
Why?
| | Symporters | 1 | 1993 | 15 | 0.100 |
Why?
| | Erythrocyte Membrane | 4 | 2001 | 14 | 0.100 |
Why?
| | Jaundice, Chronic Idiopathic | 1 | 1993 | 1 | 0.100 |
Why?
| | Crystallography, X-Ray | 5 | 2004 | 155 | 0.100 |
Why?
| | RNA, Messenger | 5 | 2014 | 1133 | 0.100 |
Why?
| | Polymerase Chain Reaction | 2 | 2016 | 452 | 0.100 |
Why?
| | Ionophores | 2 | 1991 | 4 | 0.100 |
Why?
| | Lung Neoplasms | 4 | 2003 | 645 | 0.100 |
Why?
| | Mice, Inbred C57BL | 2 | 2009 | 1925 | 0.100 |
Why?
| | Hot Temperature | 3 | 2001 | 202 | 0.100 |
Why?
| | Liver Neoplasms | 1 | 1997 | 347 | 0.100 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 6 | 2002 | 93 | 0.100 |
Why?
| | Glutathione S-Transferase pi | 7 | 2002 | 25 | 0.100 |
Why?
| | Steroids | 2 | 2004 | 61 | 0.100 |
Why?
| | Sequence Homology, Amino Acid | 4 | 2009 | 135 | 0.090 |
Why?
| | Liposomes | 6 | 2003 | 55 | 0.090 |
Why?
| | Glucagon | 2 | 1983 | 24 | 0.090 |
Why?
| | Oxidation-Reduction | 3 | 2008 | 333 | 0.090 |
Why?
| | Internationality | 1 | 2012 | 46 | 0.090 |
Why?
| | Carcinogens, Environmental | 2 | 2004 | 22 | 0.090 |
Why?
| | Electrophoresis | 2 | 2009 | 16 | 0.090 |
Why?
| | Epinephrine | 2 | 1983 | 92 | 0.090 |
Why?
| | Calcium-Binding Proteins | 2 | 1983 | 58 | 0.090 |
Why?
| | Peptide Fragments | 6 | 2009 | 209 | 0.090 |
Why?
| | Antineoplastic Agents | 4 | 2003 | 1232 | 0.090 |
Why?
| | Wound Infection | 1 | 2011 | 33 | 0.090 |
Why?
| | Sarcoplasmic Reticulum | 5 | 1991 | 21 | 0.090 |
Why?
| | Cholic Acids | 2 | 1990 | 2 | 0.090 |
Why?
| | Stereoisomerism | 6 | 2004 | 101 | 0.080 |
Why?
| | Dinitrochlorobenzene | 3 | 2001 | 5 | 0.080 |
Why?
| | Inositol Phosphates | 4 | 2002 | 14 | 0.080 |
Why?
| | Radioligand Assay | 4 | 2002 | 46 | 0.080 |
Why?
| | Bacterial Infections | 1 | 2011 | 96 | 0.080 |
Why?
| | Amiloride | 1 | 1990 | 7 | 0.080 |
Why?
| | Bicarbonates | 1 | 1990 | 16 | 0.080 |
Why?
| | Bacterial Proteins | 2 | 2004 | 349 | 0.080 |
Why?
| | Tumor Cells, Cultured | 6 | 2003 | 441 | 0.080 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1991 | 191 | 0.080 |
Why?
| | Lipids | 1 | 2011 | 163 | 0.080 |
Why?
| | Phenanthrenes | 2 | 2000 | 13 | 0.080 |
Why?
| | Anion Transport Proteins | 3 | 1994 | 4 | 0.080 |
Why?
| | Polycyclic Compounds | 2 | 2001 | 8 | 0.080 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 6 | 2007 | 71 | 0.080 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2009 | 46 | 0.080 |
Why?
| | Burns | 1 | 2011 | 164 | 0.080 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2007 | 202 | 0.070 |
Why?
| | Mixed Function Oxygenases | 1 | 1989 | 25 | 0.070 |
Why?
| | Disease Models, Animal | 4 | 2016 | 1517 | 0.070 |
Why?
| | Cell Division | 5 | 2004 | 289 | 0.070 |
Why?
| | Glucuronosyltransferase | 6 | 1991 | 121 | 0.070 |
Why?
| | Vimentin | 1 | 2009 | 31 | 0.070 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2008 | 24 | 0.070 |
Why?
| | Amino Acid Substitution | 4 | 2004 | 79 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 3 | 2005 | 175 | 0.070 |
Why?
| | Receptor, Muscarinic M3 | 3 | 2002 | 7 | 0.070 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2009 | 45 | 0.070 |
Why?
| | Retinal Pigment Epithelium | 1 | 2008 | 14 | 0.070 |
Why?
| | Female | 15 | 2016 | 28792 | 0.070 |
Why?
| | Genotype | 1 | 2009 | 563 | 0.070 |
Why?
| | Serotonin | 1 | 2009 | 144 | 0.070 |
Why?
| | Death Domain Receptor Signaling Adaptor Proteins | 1 | 2007 | 2 | 0.070 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2008 | 38 | 0.070 |
Why?
| | Fas Ligand Protein | 1 | 2007 | 16 | 0.070 |
Why?
| | Glucose Tolerance Test | 1 | 2008 | 61 | 0.070 |
Why?
| | Deoxycholic Acid | 3 | 2002 | 17 | 0.070 |
Why?
| | Catalase | 3 | 1976 | 72 | 0.070 |
Why?
| | Homeostasis | 2 | 2008 | 209 | 0.070 |
Why?
| | Models, Animal | 2 | 2005 | 233 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 7 | 2007 | 1367 | 0.070 |
Why?
| | Cells, Cultured | 7 | 2009 | 1569 | 0.060 |
Why?
| | Enzyme Stability | 2 | 1999 | 21 | 0.060 |
Why?
| | Gene Library | 2 | 2004 | 40 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2007 | 187 | 0.060 |
Why?
| | Saccharomyces cerevisiae | 3 | 1976 | 166 | 0.060 |
Why?
| | Polymorphism, Genetic | 5 | 2000 | 181 | 0.060 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 1998 | 333 | 0.060 |
Why?
| | Cholinergic Agonists | 2 | 2003 | 10 | 0.060 |
Why?
| | Cell Line, Transformed | 2 | 2004 | 73 | 0.060 |
Why?
| | Antigens, CD | 1 | 2008 | 217 | 0.060 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2008 | 228 | 0.060 |
Why?
| | Protein Kinase C | 3 | 1998 | 68 | 0.060 |
Why?
| | Molecular Weight | 4 | 1995 | 77 | 0.060 |
Why?
| | Promoter Regions, Genetic | 2 | 2005 | 465 | 0.060 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 3 | 2003 | 175 | 0.060 |
Why?
| | Neoplasm Proteins | 2 | 2003 | 330 | 0.060 |
Why?
| | Hydroxylation | 4 | 1991 | 64 | 0.060 |
Why?
| | Genetic Vectors | 2 | 2004 | 127 | 0.060 |
Why?
| | Alanine | 3 | 2004 | 43 | 0.060 |
Why?
| | Protein Isoforms | 4 | 2015 | 124 | 0.060 |
Why?
| | Nuclear Proteins | 1 | 2007 | 250 | 0.060 |
Why?
| | Insulin Resistance | 1 | 2008 | 282 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2011 | 815 | 0.060 |
Why?
| | Transcription Factors | 2 | 2007 | 571 | 0.060 |
Why?
| | Guinea Pigs | 2 | 2003 | 75 | 0.060 |
Why?
| | Carbon Tetrachloride | 1 | 2005 | 25 | 0.060 |
Why?
| | Receptors, Steroid | 1 | 2005 | 20 | 0.060 |
Why?
| | Epithelium, Corneal | 1 | 2005 | 10 | 0.060 |
Why?
| | DNA Primers | 3 | 2011 | 202 | 0.060 |
Why?
| | N-Methylscopolamine | 2 | 2002 | 3 | 0.060 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 65 | 0.060 |
Why?
| | Magnetic Resonance Spectroscopy | 8 | 1992 | 250 | 0.060 |
Why?
| | Multidrug Resistance-Associated Proteins | 3 | 2001 | 17 | 0.060 |
Why?
| | Protein Conformation | 3 | 2002 | 174 | 0.060 |
Why?
| | Blood Glucose | 1 | 2008 | 491 | 0.060 |
Why?
| | Steroid Isomerases | 1 | 2004 | 1 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 4 | 1996 | 169 | 0.050 |
Why?
| | Models, Biological | 4 | 2008 | 737 | 0.050 |
Why?
| | Forkhead Transcription Factors | 1 | 2005 | 120 | 0.050 |
Why?
| | Peptide Mapping | 5 | 1996 | 25 | 0.050 |
Why?
| | DNA, Complementary | 2 | 2002 | 128 | 0.050 |
Why?
| | Phosphatidylcholines | 2 | 2001 | 25 | 0.050 |
Why?
| | Insulin | 2 | 2005 | 493 | 0.050 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2005 | 187 | 0.050 |
Why?
| | Subcellular Fractions | 2 | 2001 | 33 | 0.050 |
Why?
| | Stress, Psychological | 1 | 2006 | 283 | 0.050 |
Why?
| | Rats, Mutant Strains | 3 | 1993 | 10 | 0.050 |
Why?
| | Oxidants | 2 | 2011 | 51 | 0.050 |
Why?
| | Lactones | 1 | 2004 | 25 | 0.050 |
Why?
| | Gene Expression Regulation | 2 | 2006 | 1003 | 0.050 |
Why?
| | Islets of Langerhans | 1 | 2004 | 27 | 0.050 |
Why?
| | Microsomes | 2 | 1983 | 35 | 0.050 |
Why?
| | Blotting, Southern | 1 | 2004 | 40 | 0.050 |
Why?
| | Gene Deletion | 2 | 2015 | 279 | 0.050 |
Why?
| | Arteriosclerosis | 1 | 2004 | 49 | 0.050 |
Why?
| | Malondialdehyde | 1 | 2004 | 55 | 0.050 |
Why?
| | Egtazic Acid | 1 | 2003 | 10 | 0.050 |
Why?
| | Vinca Alkaloids | 1 | 2003 | 1 | 0.050 |
Why?
| | Calcium-Transporting ATPases | 4 | 1991 | 12 | 0.050 |
Why?
| | Hydrogen Peroxide | 2 | 2011 | 121 | 0.050 |
Why?
| | Plasmids | 1 | 2004 | 165 | 0.050 |
Why?
| | GTP-Binding Proteins | 1 | 2003 | 85 | 0.050 |
Why?
| | Mice, Inbred BALB C | 1 | 2004 | 310 | 0.050 |
Why?
| | Epoxy Compounds | 2 | 2000 | 47 | 0.050 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2003 | 87 | 0.050 |
Why?
| | Multigene Family | 1 | 2003 | 50 | 0.050 |
Why?
| | Drosophila Proteins | 1 | 2003 | 26 | 0.050 |
Why?
| | Tetrazolium Salts | 2 | 2003 | 13 | 0.050 |
Why?
| | Conserved Sequence | 1 | 2003 | 55 | 0.050 |
Why?
| | Thiotepa | 2 | 2000 | 6 | 0.050 |
Why?
| | Garlic | 1 | 2002 | 5 | 0.050 |
Why?
| | Arginine | 2 | 2001 | 178 | 0.050 |
Why?
| | Crystallization | 2 | 1999 | 33 | 0.050 |
Why?
| | Down-Regulation | 3 | 2011 | 344 | 0.050 |
Why?
| | Allyl Compounds | 1 | 2002 | 11 | 0.050 |
Why?
| | Disulfides | 1 | 2002 | 18 | 0.050 |
Why?
| | Acetylcholinesterase | 1 | 2002 | 21 | 0.050 |
Why?
| | Thiazoles | 2 | 2003 | 52 | 0.050 |
Why?
| | Colchicine | 2 | 2001 | 25 | 0.050 |
Why?
| | Anticarcinogenic Agents | 1 | 2002 | 32 | 0.050 |
Why?
| | Muscle, Smooth | 1 | 2002 | 62 | 0.050 |
Why?
| | Binding, Competitive | 3 | 1998 | 89 | 0.050 |
Why?
| | Phytotherapy | 1 | 2002 | 45 | 0.050 |
Why?
| | Antineoplastic Agents, Alkylating | 2 | 2000 | 78 | 0.050 |
Why?
| | Immunoglobulin G | 4 | 2003 | 192 | 0.050 |
Why?
| | Survival Analysis | 1 | 2004 | 659 | 0.040 |
Why?
| | Chromatography, Thin Layer | 5 | 2002 | 20 | 0.040 |
Why?
| | Phylogeny | 1 | 2003 | 231 | 0.040 |
Why?
| | Aorta, Thoracic | 1 | 2002 | 101 | 0.040 |
Why?
| | Protein Binding | 2 | 2001 | 670 | 0.040 |
Why?
| | Carcinoma, Small Cell | 4 | 2003 | 26 | 0.040 |
Why?
| | Bone Density | 1 | 2004 | 398 | 0.040 |
Why?
| | Body Composition | 1 | 2004 | 355 | 0.040 |
Why?
| | Coronary Artery Disease | 1 | 2005 | 324 | 0.040 |
Why?
| | Indicators and Reagents | 1 | 2001 | 36 | 0.040 |
Why?
| | Quaternary Ammonium Compounds | 1 | 1981 | 29 | 0.040 |
Why?
| | Leucine | 2 | 1999 | 114 | 0.040 |
Why?
| | Methyltransferases | 1 | 1981 | 28 | 0.040 |
Why?
| | Chlorambucil | 1 | 2000 | 4 | 0.040 |
Why?
| | Antiporters | 1 | 1980 | 19 | 0.040 |
Why?
| | Phenotype | 1 | 2004 | 803 | 0.040 |
Why?
| | Cation Transport Proteins | 1 | 1980 | 26 | 0.040 |
Why?
| | Hepatocytes | 1 | 2001 | 188 | 0.040 |
Why?
| | Antioxidants | 1 | 2002 | 264 | 0.040 |
Why?
| | Time Factors | 5 | 2003 | 2992 | 0.040 |
Why?
| | Alkanesulfonic Acids | 1 | 1999 | 11 | 0.040 |
Why?
| | Enzyme Precursors | 2 | 1976 | 5 | 0.040 |
Why?
| | Morpholines | 1 | 1999 | 64 | 0.040 |
Why?
| | Tissue Distribution | 2 | 2002 | 174 | 0.040 |
Why?
| | Valinomycin | 2 | 1994 | 2 | 0.040 |
Why?
| | Pancreas | 2 | 2001 | 72 | 0.040 |
Why?
| | Membranes, Artificial | 2 | 1994 | 15 | 0.040 |
Why?
| | Formazans | 1 | 1998 | 2 | 0.040 |
Why?
| | Metabolism, Inborn Errors | 1 | 1998 | 18 | 0.040 |
Why?
| | DNA Adducts | 1 | 1999 | 79 | 0.040 |
Why?
| | Oxygen Consumption | 2 | 1976 | 202 | 0.040 |
Why?
| | Solvents | 2 | 1997 | 32 | 0.040 |
Why?
| | Cholagogues and Choleretics | 1 | 1998 | 5 | 0.030 |
Why?
| | Oxygen | 1 | 2001 | 338 | 0.030 |
Why?
| | Receptors, Cholinergic | 1 | 1998 | 14 | 0.030 |
Why?
| | Microvilli | 1 | 1998 | 6 | 0.030 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 1998 | 45 | 0.030 |
Why?
| | Glutamic Acid | 1 | 1999 | 105 | 0.030 |
Why?
| | Reference Values | 2 | 2004 | 311 | 0.030 |
Why?
| | Methionine | 1 | 1999 | 142 | 0.030 |
Why?
| | Enzyme Activation | 3 | 2004 | 267 | 0.030 |
Why?
| | Atropine | 3 | 2003 | 30 | 0.030 |
Why?
| | HEPES | 1 | 1997 | 2 | 0.030 |
Why?
| | Static Electricity | 1 | 1997 | 22 | 0.030 |
Why?
| | DNA Damage | 1 | 1999 | 309 | 0.030 |
Why?
| | Carbachol | 3 | 2002 | 26 | 0.030 |
Why?
| | Benzene Derivatives | 1 | 1997 | 7 | 0.030 |
Why?
| | T-Lymphocyte Subsets | 1 | 1997 | 39 | 0.030 |
Why?
| | Caspase 3 | 2 | 2007 | 92 | 0.030 |
Why?
| | Rats, Inbred F344 | 3 | 1992 | 194 | 0.030 |
Why?
| | Protein Denaturation | 1 | 1996 | 16 | 0.030 |
Why?
| | Ethacrynic Acid | 1 | 1996 | 3 | 0.030 |
Why?
| | Diuretics | 1 | 1996 | 27 | 0.030 |
Why?
| | Uterus | 1 | 1997 | 81 | 0.030 |
Why?
| | Cell Survival | 4 | 2007 | 600 | 0.030 |
Why?
| | Adaptation, Physiological | 1 | 1976 | 109 | 0.030 |
Why?
| | Protein Carbonylation | 1 | 2015 | 4 | 0.030 |
Why?
| | Transcription, Genetic | 2 | 2011 | 374 | 0.030 |
Why?
| | Rabbits | 5 | 1991 | 372 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 2 | 2009 | 109 | 0.030 |
Why?
| | Methylation | 3 | 1992 | 127 | 0.030 |
Why?
| | Microscopy, Fluorescence | 2 | 2007 | 140 | 0.030 |
Why?
| | Chemokine CXCL2 | 1 | 2014 | 11 | 0.030 |
Why?
| | Endothelium, Vascular | 1 | 1996 | 262 | 0.030 |
Why?
| | Vanadates | 1 | 1994 | 7 | 0.030 |
Why?
| | Ethylmaleimide | 1 | 1994 | 2 | 0.030 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 19 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2014 | 47 | 0.030 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1994 | 27 | 0.030 |
Why?
| | Eye | 1 | 1995 | 29 | 0.030 |
Why?
| | Alanine Transaminase | 1 | 2014 | 118 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2016 | 243 | 0.030 |
Why?
| | Antibodies | 1 | 2014 | 147 | 0.030 |
Why?
| | Actins | 1 | 2014 | 114 | 0.030 |
Why?
| | Drug Resistance | 3 | 2003 | 71 | 0.030 |
Why?
| | Genetic Variation | 3 | 2000 | 223 | 0.030 |
Why?
| | Membrane Transport Proteins | 3 | 1999 | 46 | 0.030 |
Why?
| | Daunorubicin | 1 | 1994 | 15 | 0.030 |
Why?
| | Vinblastine | 1 | 1994 | 22 | 0.030 |
Why?
| | Fibrosis | 1 | 2014 | 198 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2014 | 136 | 0.030 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 1994 | 65 | 0.030 |
Why?
| | Transcriptome | 1 | 2016 | 368 | 0.030 |
Why?
| | Muscles | 2 | 1992 | 110 | 0.020 |
Why?
| | Perfusion | 2 | 1990 | 49 | 0.020 |
Why?
| | Bilirubin | 1 | 1993 | 43 | 0.020 |
Why?
| | Dose-Response Relationship, Immunologic | 2 | 2003 | 13 | 0.020 |
Why?
| | Sheep | 1 | 1993 | 99 | 0.020 |
Why?
| | Testis | 2 | 2005 | 74 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 3 | 2002 | 1544 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 392 | 0.020 |
Why?
| | In Situ Nick-End Labeling | 2 | 2004 | 54 | 0.020 |
Why?
| | Leukotrienes | 1 | 1992 | 9 | 0.020 |
Why?
| | Methylamines | 2 | 1983 | 23 | 0.020 |
Why?
| | HL-60 Cells | 2 | 2003 | 19 | 0.020 |
Why?
| | S-Adenosylmethionine | 2 | 1983 | 62 | 0.020 |
Why?
| | Molecular Structure | 3 | 2000 | 320 | 0.020 |
Why?
| | Affinity Labels | 1 | 1991 | 5 | 0.020 |
Why?
| | Uridine Diphosphate Glucuronic Acid | 1 | 1991 | 9 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2011 | 37 | 0.020 |
Why?
| | Chemistry, Physical | 1 | 1991 | 6 | 0.020 |
Why?
| | Chemical Phenomena | 1 | 1991 | 13 | 0.020 |
Why?
| | Solutions | 1 | 1991 | 24 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 627 | 0.020 |
Why?
| | Pseudomonas Infections | 1 | 2011 | 54 | 0.020 |
Why?
| | Androstenedione | 1 | 1991 | 5 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2011 | 96 | 0.020 |
Why?
| | Bile Ducts | 1 | 1991 | 48 | 0.020 |
Why?
| | Clofibrate | 1 | 1991 | 7 | 0.020 |
Why?
| | Steroid Hydroxylases | 1 | 1991 | 18 | 0.020 |
Why?
| | Myocardium | 1 | 1994 | 471 | 0.020 |
Why?
| | Molecular Conformation | 2 | 2004 | 66 | 0.020 |
Why?
| | Phenobarbital | 1 | 1991 | 17 | 0.020 |
Why?
| | Enzyme Induction | 1 | 1991 | 75 | 0.020 |
Why?
| | Sulfurtransferases | 1 | 1990 | 3 | 0.020 |
Why?
| | Cytosol | 2 | 2007 | 80 | 0.020 |
Why?
| | Drug Resistance, Multiple | 2 | 2002 | 25 | 0.020 |
Why?
| | Brain | 2 | 2001 | 1353 | 0.020 |
Why?
| | Immunohistochemistry | 2 | 2004 | 975 | 0.020 |
Why?
| | Cholic Acid | 1 | 1990 | 1 | 0.020 |
Why?
| | Taurocholic Acid | 1 | 1990 | 5 | 0.020 |
Why?
| | Sulfotransferases | 1 | 1990 | 38 | 0.020 |
Why?
| | Liver Circulation | 1 | 1990 | 21 | 0.020 |
Why?
| | Drug Interactions | 2 | 2003 | 196 | 0.020 |
Why?
| | Azides | 2 | 2001 | 9 | 0.020 |
Why?
| | Photoaffinity Labels | 2 | 2001 | 15 | 0.020 |
Why?
| | NADPH Dehydrogenase | 1 | 1989 | 9 | 0.020 |
Why?
| | Biotinylation | 1 | 2009 | 28 | 0.020 |
Why?
| | Glutathione Disulfide | 2 | 2000 | 38 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2011 | 774 | 0.020 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 1989 | 71 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 68 | 0.020 |
Why?
| | Cell Line, Tumor | 2 | 2003 | 1470 | 0.020 |
Why?
| | Dexamethasone | 1 | 1991 | 429 | 0.020 |
Why?
| | Models, Chemical | 2 | 1999 | 65 | 0.020 |
Why?
| | Precipitin Tests | 2 | 2002 | 33 | 0.020 |
Why?
| | Survival Rate | 1 | 2011 | 949 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2011 | 1212 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2008 | 252 | 0.020 |
Why?
| | Anthracenes | 1 | 2007 | 9 | 0.020 |
Why?
| | Caspase 8 | 1 | 2007 | 10 | 0.020 |
Why?
| | MAP Kinase Kinase Kinase 5 | 1 | 2007 | 3 | 0.020 |
Why?
| | Organ Specificity | 2 | 2001 | 115 | 0.020 |
Why?
| | Jurkat Cells | 1 | 2007 | 28 | 0.020 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 1 | 1987 | 3 | 0.020 |
Why?
| | Co-Repressor Proteins | 1 | 2007 | 17 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2007 | 56 | 0.020 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2007 | 71 | 0.020 |
Why?
| | Molecular Chaperones | 1 | 2007 | 76 | 0.020 |
Why?
| | Protein Transport | 1 | 2007 | 168 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2007 | 214 | 0.020 |
Why?
| | Blood Platelets | 1 | 2009 | 247 | 0.020 |
Why?
| | Isoelectric Point | 2 | 1998 | 4 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 2006 | 25 | 0.020 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2006 | 30 | 0.020 |
Why?
| | Lens, Crystalline | 1 | 2006 | 19 | 0.020 |
Why?
| | Cell Separation | 2 | 2001 | 76 | 0.020 |
Why?
| | Caspases | 1 | 2006 | 101 | 0.010 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 2005 | 8 | 0.010 |
Why?
| | Paraquat | 1 | 2005 | 5 | 0.010 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2005 | 19 | 0.010 |
Why?
| | Prospective Studies | 1 | 2011 | 2412 | 0.010 |
Why?
| | Cytoskeletal Proteins | 1 | 2005 | 46 | 0.010 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2005 | 47 | 0.010 |
Why?
| | Pregnancy | 3 | 1998 | 2610 | 0.010 |
Why?
| | Superoxide Dismutase | 1 | 2005 | 122 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2007 | 423 | 0.010 |
Why?
| | Spleen | 1 | 2005 | 166 | 0.010 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2005 | 141 | 0.010 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2004 | 35 | 0.010 |
Why?
| | Microinjections | 1 | 2004 | 34 | 0.010 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 64 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2005 | 561 | 0.010 |
Why?
| | Cattle | 2 | 1996 | 207 | 0.010 |
Why?
| | Glutamate-Ammonia Ligase | 1 | 1983 | 10 | 0.010 |
Why?
| | Tyrphostins | 1 | 2003 | 10 | 0.010 |
Why?
| | Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2003 | 7 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 46 | 0.010 |
Why?
| | Kidney | 1 | 1988 | 717 | 0.010 |
Why?
| | Calcium Radioisotopes | 1 | 1983 | 7 | 0.010 |
Why?
| | Drug Design | 1 | 2004 | 121 | 0.010 |
Why?
| | Quinazolines | 1 | 2003 | 34 | 0.010 |
Why?
| | Xanthine Oxidase | 1 | 2003 | 13 | 0.010 |
Why?
| | GTP Phosphohydrolases | 1 | 2003 | 29 | 0.010 |
Why?
| | S-Adenosylhomocysteine | 1 | 1983 | 47 | 0.010 |
Why?
| | Ultraviolet Rays | 1 | 2003 | 50 | 0.010 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2004 | 136 | 0.010 |
Why?
| | Flavonoids | 1 | 2003 | 55 | 0.010 |
Why?
| | Transcriptional Activation | 1 | 2003 | 128 | 0.010 |
Why?
| | Trypsin | 1 | 2003 | 11 | 0.010 |
Why?
| | U937 Cells | 1 | 2003 | 14 | 0.010 |
Why?
| | Inhibitory Concentration 50 | 1 | 2003 | 75 | 0.010 |
Why?
| | Sex Factors | 1 | 2005 | 747 | 0.010 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2003 | 46 | 0.010 |
Why?
| | Cell Cycle | 1 | 2004 | 237 | 0.010 |
Why?
| | Computational Biology | 1 | 2004 | 209 | 0.010 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2003 | 187 | 0.010 |
Why?
| | Cross Reactions | 1 | 2003 | 42 | 0.010 |
Why?
| | Intracellular Membranes | 1 | 1983 | 22 | 0.010 |
Why?
| | Mice, Inbred A | 1 | 2002 | 14 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2003 | 148 | 0.010 |
Why?
| | Catalytic Domain | 1 | 2002 | 60 | 0.010 |
Why?
| | Cholinesterases | 1 | 2002 | 2 | 0.010 |
Why?
| | Mass Spectrometry | 3 | 1992 | 294 | 0.010 |
Why?
| | Selenium | 1 | 2002 | 8 | 0.010 |
Why?
| | Osmolar Concentration | 2 | 1999 | 61 | 0.010 |
Why?
| | Tritium | 1 | 2002 | 43 | 0.010 |
Why?
| | Adenosine Monophosphate | 1 | 2002 | 14 | 0.010 |
Why?
| | Glycine | 1 | 2002 | 75 | 0.010 |
Why?
| | Filtration | 1 | 2002 | 19 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2004 | 289 | 0.010 |
Why?
| | Intestine, Small | 1 | 2002 | 114 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2004 | 869 | 0.010 |
Why?
| | Hydrolysis | 2 | 1992 | 67 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2001 | 106 | 0.010 |
Why?
| | Heat-Shock Response | 1 | 2001 | 29 | 0.010 |
Why?
| | Isoelectric Focusing | 1 | 2001 | 8 | 0.010 |
Why?
| | Cations | 1 | 1981 | 9 | 0.010 |
Why?
| | Transcription Factor AP-1 | 1 | 2001 | 62 | 0.010 |
Why?
| | Phosphorus Radioisotopes | 1 | 2001 | 7 | 0.010 |
Why?
| | Antibody Specificity | 1 | 2001 | 36 | 0.010 |
Why?
| | Culture Media | 1 | 2001 | 97 | 0.010 |
Why?
| | DNA Fragmentation | 1 | 2001 | 53 | 0.010 |
Why?
| | Haptens | 1 | 2001 | 10 | 0.010 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2003 | 238 | 0.010 |
Why?
| | Sulfuric Acids | 2 | 1991 | 8 | 0.010 |
Why?
| | Amino Acid Motifs | 1 | 2001 | 59 | 0.010 |
Why?
| | Phenylmethylsulfonyl Fluoride | 1 | 2001 | 1 | 0.010 |
Why?
| | Brain Chemistry | 1 | 2001 | 68 | 0.010 |
Why?
| | ral GTP-Binding Proteins | 1 | 2001 | 3 | 0.010 |
Why?
| | Metals, Rare Earth | 1 | 1980 | 1 | 0.010 |
Why?
| | Lanthanum | 1 | 1980 | 4 | 0.010 |
Why?
| | Ruthenium Red | 1 | 1980 | 5 | 0.010 |
Why?
| | Isomerism | 1 | 2000 | 23 | 0.010 |
Why?
| | Alkylating Agents | 1 | 2000 | 22 | 0.010 |
Why?
| | Intracellular Fluid | 1 | 2000 | 11 | 0.010 |
Why?
| | Acrolein | 1 | 2000 | 3 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2005 | 1112 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2000 | 163 | 0.010 |
Why?
| | Erythropoiesis | 1 | 1999 | 18 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2001 | 400 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 1999 | 33 | 0.010 |
Why?
| | Dimerization | 1 | 1999 | 50 | 0.010 |
Why?
| | Cross-Linking Reagents | 1 | 1999 | 43 | 0.010 |
Why?
| | Leukotriene C4 | 1 | 1999 | 1 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 477 | 0.010 |
Why?
| | Glycosides | 1 | 1979 | 15 | 0.010 |
Why?
| | Laryngeal Neoplasms | 1 | 1999 | 44 | 0.010 |
Why?
| | Baculoviridae | 1 | 1998 | 5 | 0.010 |
Why?
| | Parenteral Nutrition, Total | 1 | 1998 | 28 | 0.010 |
Why?
| | Glucosides | 1 | 1979 | 21 | 0.010 |
Why?
| | Anilino Naphthalenesulfonates | 1 | 1978 | 5 | 0.010 |
Why?
| | False Positive Reactions | 1 | 1998 | 66 | 0.010 |
Why?
| | Gene Transfer Techniques | 1 | 1998 | 44 | 0.010 |
Why?
| | Pepsinogens | 1 | 1998 | 1 | 0.010 |
Why?
| | Sincalide | 1 | 1998 | 3 | 0.010 |
Why?
| | 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1998 | 3 | 0.010 |
Why?
| | Parasympatholytics | 1 | 1998 | 11 | 0.010 |
Why?
| | Fluorescence | 1 | 1978 | 30 | 0.010 |
Why?
| | Cell Count | 1 | 1998 | 141 | 0.010 |
Why?
| | Cholecystokinin | 1 | 1998 | 23 | 0.010 |
Why?
| | Fluoresceins | 1 | 1998 | 9 | 0.010 |
Why?
| | Osmotic Pressure | 1 | 1998 | 10 | 0.010 |
Why?
| | Air Pollutants | 1 | 1999 | 75 | 0.010 |
Why?
| | Caco-2 Cells | 1 | 1998 | 31 | 0.010 |
Why?
| | Spectrometry, Fluorescence | 1 | 1998 | 45 | 0.010 |
Why?
| | Amino Acids | 1 | 2000 | 382 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 1998 | 90 | 0.010 |
Why?
| | Benzo(a)pyrene | 1 | 1997 | 13 | 0.010 |
Why?
| | Temperature | 1 | 1998 | 165 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 1997 | 69 | 0.010 |
Why?
| | Cell Differentiation | 1 | 1999 | 681 | 0.010 |
Why?
| | Microbodies | 1 | 1976 | 3 | 0.010 |
Why?
| | Bone Marrow Cells | 1 | 1997 | 188 | 0.010 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 1996 | 136 | 0.010 |
Why?
| | Carcinoma, Squamous Cell | 1 | 1999 | 332 | 0.010 |
Why?
| | Organoids | 1 | 1976 | 41 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 1999 | 533 | 0.010 |
Why?
| | Heme | 1 | 1975 | 20 | 0.010 |
Why?
| | Sepsis | 1 | 1998 | 240 | 0.010 |
Why?
| | Algorithms | 1 | 1999 | 668 | 0.010 |
Why?
| | Consensus Sequence | 1 | 1994 | 22 | 0.010 |
Why?
| | Pregnancy Complications | 1 | 1998 | 406 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1994 | 119 | 0.010 |
Why?
| | Adult | 3 | 2001 | 14541 | 0.010 |
Why?
| | Chickens | 1 | 1994 | 106 | 0.010 |
Why?
| | Placenta | 1 | 1994 | 146 | 0.010 |
Why?
| | Metals | 1 | 1992 | 37 | 0.010 |
Why?
| | Esterification | 1 | 1992 | 6 | 0.010 |
Why?
| | Acetylation | 1 | 1992 | 97 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 1978 | 832 | 0.010 |
Why?
| | Uridine Diphosphate Glucose Dehydrogenase | 1 | 1991 | 1 | 0.010 |
Why?
| | Photochemistry | 1 | 1991 | 8 | 0.010 |
Why?
| | Ligation | 1 | 1991 | 63 | 0.010 |
Why?
| | Infant, Newborn | 1 | 1998 | 2913 | 0.010 |
Why?
| | Sulfobromophthalein | 1 | 1989 | 3 | 0.000 |
Why?
| | Androstanols | 1 | 1989 | 5 | 0.000 |
Why?
| | Neoplasms | 1 | 2000 | 1335 | 0.000 |
Why?
| | Calcimycin | 1 | 1989 | 5 | 0.000 |
Why?
| | Ionomycin | 1 | 1988 | 4 | 0.000 |
Why?
| | Ethers | 1 | 1988 | 7 | 0.000 |
Why?
| | Cell Membrane Permeability | 1 | 1988 | 24 | 0.000 |
Why?
| | L-Lactate Dehydrogenase | 1 | 1988 | 57 | 0.000 |
Why?
| | Ca(2+) Mg(2+)-ATPase | 1 | 1988 | 1 | 0.000 |
Why?
| | 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) | 1 | 1987 | 1 | 0.000 |
Why?
| | Swine | 1 | 1988 | 440 | 0.000 |
Why?
| | Scintillation Counting | 1 | 1986 | 1 | 0.000 |
Why?
| | Spectrum Analysis | 1 | 1986 | 50 | 0.000 |
Why?
| | Chromatography, Gas | 1 | 1986 | 15 | 0.000 |
Why?
| | Infusions, Intravenous | 1 | 1986 | 211 | 0.000 |
Why?
| | Aged | 2 | 1990 | 10430 | 0.000 |
Why?
| | Methionine Sulfoximine | 1 | 1983 | 7 | 0.000 |
Why?
| | Chloroform | 1 | 1980 | 5 | 0.000 |
Why?
| | Methanol | 1 | 1980 | 10 | 0.000 |
Why?
| | Chromatography, Gel | 1 | 1980 | 38 | 0.000 |
Why?
| | Diacylglycerol Cholinephosphotransferase | 1 | 1980 | 1 | 0.000 |
Why?
| | Ethanolaminephosphotransferase | 1 | 1980 | 1 | 0.000 |
Why?
| | Centrifugation, Density Gradient | 1 | 1980 | 16 | 0.000 |
Why?
| | Muscle Development | 1 | 1980 | 24 | 0.000 |
Why?
| | Adolescent | 1 | 1990 | 6912 | 0.000 |
Why?
| | Potassium Chloride | 1 | 1979 | 17 | 0.000 |
Why?
| | Child, Preschool | 1 | 1987 | 4164 | 0.000 |
Why?
| | Child | 1 | 1990 | 7384 | 0.000 |
Why?
| | Ultracentrifugation | 1 | 1976 | 10 | 0.000 |
Why?
| | Spheroplasts | 1 | 1976 | 4 | 0.000 |
Why?
| | Fungal Proteins | 1 | 1976 | 110 | 0.000 |
Why?
| | Middle Aged | 1 | 1990 | 13422 | 0.000 |
Why?
|
|
Zimniak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|